Regenxbio (RGNX) hit by FDA CRL for RGX-121; valuation discount, cash runway to 2027, risks vs RGX-202 upside. Click here to ...

REGENXBIO (NASDAQ:RGNX) outlined a slate of near-term clinical catalysts and provided financial updates during its fourth-quarter and year-end 2025 earnings call, emphasizing what management described ...

Expression Design 4, Microsoft’s vector graphics design tool, has been quietly killed and is no longer available for sale nor will there be any new versions developed by Microsoft. The software is now ...

Thanks, everyone, for being here for TD Cowen's 46th Annual Healthcare Conference. Our next session we have here is with Rocket Pharma. And from Rocket, we have Gaurav Shah, the CEO. Thanks so much ...

From analytical control through downstream processes to manufacturing, BsAbs present challenges in protein expression, purity, and stability.

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Allegations of sexual harassment, stalking and sexual assault have increased at UC Berkeley compared to last year, according ...

In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial ...

A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated next-generation viral vectors with ...

Allegations of sexual harassment, stalking and sexual assault have increased at UC Berkeley compared to last year, according to campus’s 2025 Civil Rights Report.

Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...

Naked mRNA administration in the testes rescues sperm function, demonstrating a potential therapeutic approach for genetic male infertility.